#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infective uveitis Obesity Corneal neovascularisation Ehlers-Danlos syndrome Hepatitis B Polymyositis Juvenile chronic myelomonocytic leukaemia Restless legs syndrome Neurodevelopmental disorder Acute graft versus host disease Crigler-Najjar syndrome Rhabdomyosarcoma Henoch-Schonlein purpura nephritis Deafness bilateral Still's disease More trials…

    Learn about Rare Diseases

    Retinitis pigmentosa – Basic Information Hypereosinophilic syndrome – Life with Disease Pleural mesothelioma malignant – Treatment Synovial sarcoma recurrent – Life with Disease Indolent systemic mastocytosis – Trials in Disease Pemphigus – Basic Information Angiosarcoma – Diagnostics Sarcoma – Trials in Disease Richter’s syndrome – Life with Disease Hereditary neuropathic amyloidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Odm-212 SULBACTAM SODIUM Vepdegestrant Cefuroxime Axetil Ravulizumab Sabirnetug Zamtocabtagene Autoleucel Desonide Human Plasma Protein Gadobenate Dimeglumine Nesolicaftor Vgl101 Senicapoc Tirzepatide Tinengotinib Keto-Valine Calcium Fasudil Hydrochloride Nirmatrelvir Dexibuprofen Hydrocortisone Acetate More therapies…

    Learn about Your Condition

    Hypertriglyceridaemia Pulmonary sarcoidosis Neuromuscular scoliosis Prolymphocytic leukaemia Pancreatitis chronic Altered state of consciousness Peritoneal cancer index Eye pain Raynaud's phenomenon Congenital pseudarthrosis Carotid artery stenosis Hypereosinophilic syndrome Hereditary optic atrophy Ectopic pregnancy Primary amyloidosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Sud Francilien

Centre Hospitalier Sud Francilien

40 Avenue Serge Dassault, Corbeil Essonnes, 91100, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    • Milvexian
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Study on Preventing Low Calcium Levels After Thyroid Surgery with Preoperative Cholecalciferol Supplementation for Patients Undergoing Total Thyroidectomy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypocalcaemia
    • Thyroidectomy
    Investigated Drugs:
    • Colecalciferol
    France

  • Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Bortezomib
    • Dexamethasone
    • Isatuximab
    France

  • Study Comparing Anakinra and Prednisone for Treating Gout Flare in Patients with Advanced Kidney Disease or Kidney Transplant

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Renal failure
    Investigated Drugs:
    • Anakinra
    • Prednisone
    France

  • Study on Improving Survival in Acute Myeloid Leukemia for Adults Aged 18-60 Using Idarubicin, Daunorubicin, Cytarabine, and Mycophenolic Acid

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cytarabine
    • Venetoclax
    France

  • Study on Stopping and Restarting Acalabrutinib in Elderly Patients with Untreated Chronic Lymphocytic Leukemia (CLL)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Acalabrutinib
    France

  • Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Austria Belgium Czechia Denmark Finland France +7
Previous Page
1 … 6 7 8

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!